thiotepa has been researched along with Delayed Hypersensitivity in 3 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of anti-cancer agents on the delayed hypersensitivity reaction was thought to be due to elimination of suppressor T cell activity." | 1.26 | Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon. ( Goto, M; Kitano, M; Mitsuoka, A; Sugiyama, M, 1981) |
| "Patients with recurrent superficial bladder tumors have been treated by vesical and intradermal administration of Bacillus Calmette-Guerin." | 1.26 | Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. ( Bruce, AW; Eidinger, D; Morales, A, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, M | 1 |
| Mitsuoka, A | 1 |
| Sugiyama, M | 1 |
| Kitano, M | 1 |
| Morales, A | 1 |
| Eidinger, D | 1 |
| Bruce, AW | 1 |
| Venenson, EV | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intravesical Instillation Therapy With Bacillus Calmette-Guérin (BCG) and Sequential BCG and Electromotive Mitomycin-C (EMDA-MCC) in Patients With High-risk Non-muscle-invasive Bladder Carcinoma[NCT03664869] | Phase 3 | 300 participants (Anticipated) | Interventional | 2018-10-26 | Recruiting | ||
| The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study[NCT03597087] | 289 participants (Anticipated) | Interventional | 2018-07-19 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for thiotepa and Delayed Hypersensitivity
| Article | Year |
|---|---|
Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon.
Topics: Animals; Antineoplastic Agents; Carbazilquinone; Cell Cycle; Cyclophosphamide; Humans; Hypersensitiv | 1981 |
Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.
Topics: Aged; BCG Vaccine; Carcinoma, Transitional Cell; Female; Humans; Hypersensitivity, Delayed; Immunoth | 1976 |
Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.
Topics: Aged; BCG Vaccine; Carcinoma, Transitional Cell; Female; Humans; Hypersensitivity, Delayed; Immunoth | 1976 |
Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.
Topics: Aged; BCG Vaccine; Carcinoma, Transitional Cell; Female; Humans; Hypersensitivity, Delayed; Immunoth | 1976 |
Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.
Topics: Aged; BCG Vaccine; Carcinoma, Transitional Cell; Female; Humans; Hypersensitivity, Delayed; Immunoth | 1976 |
[Mechanism of action of cytostatic agents in rheumatoid arthritis].
Topics: Adult; Antibodies; Antineoplastic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Chlorambucil; | 1974 |